GSK-200879

Study Sponsor: GSK

Study Title

A Phase IIb, Randomized (Stratified), Double-Blind (Sponsor Open), Parallel-Group, Placebo-Controlled, Dose-Finding Study of Nemiralisib (GSK2269557) Added to Standard of Care (SoC) Versus SoC Alone in Participants Diagnosed with an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Medicine or Vaccine (generic name)

nemiralisib

Sponsor Identification Number

200879

Trial Registry Identification Number(#'s)

NCT03345407

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=200879

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03345407

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2017-001074-42

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

June 2021